Magda Wierzycka – CEO of Sygnia, bought shares in OSI, a company that transforms patents from Oxford University into viable businesses. OSI has shares in Vaccitech, a company ahead of the race in the Covid-19 vaccine.
This article is exclusive to Biznews Premium. Members please login here. Not yet subscribed? Taste before you eat by signing up here for free 30 day trial (card details required).
Source: biznews.com
